Colorectal Cancer: Clinical Trials

5 trials of Colorectal Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 1 active not recruiting. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1

Follow Colorectal Cancer: new trials by email Literature Review of Colorectal Cancer trials Research Report on Colorectal Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Precision-MRD: Prospective Observational Study of Biomarker-directed Systemic Therapy for Colorectal Cancer Patients With Minimal Residual Disease
Colorectal Cancer - Colorectal Cancer
RecruitingM.D. Anderson Cancer Center402025-04-182026-05-22
Impact of Environmental Factors and Metabolomics on Colorectal Cancer.
colorectal cancer, colorectal neoplasm - Colorectal Cancer, Metabolic Disease
Active not recruitingDong Peng7002024-10-012024-10-16
Impacts of Alcohol Warning Labels: An Online Experiment
Liver Cancer, Throat and Mouth Cancer, Colorectal Cancer - Alcohol Drinking
Not applicableCompletedUniversity of North Carolina, Chapel Hill11232024-09-252025-08-15
Early-Onset Colorectal Cancer Patients Too Young for Screening
Colorectal cancer - Colorectal Cancer
RecruitingMethodist Health System1002020-01-312026-04-30
PRESEPT Study: Evaluation of SEPT9 Biomarker Performance for Colorectal Cancer Screening
All eligible subjects will provide blood for SEPT9 biomarker testing - Colorectal Cancer
CompletedEpigenomics, Inc79292008-06-012014-08-04

Conditions studied

Colorectal Neoplasms (4)  ·  Alcohol Drinking (1)  ·  Metabolic Diseases (1)

Sponsors

Dong Peng (1)  ·  Epigenomics, Inc (1)  ·  M.D. Anderson Cancer Center (1)  ·  Methodist Health System (1)  ·  University of North Carolina, Chapel Hill (1)

Countries

United States (4)  ·  China (1)  ·  Germany (1)

Top investigators

Anna Grummon, PhD (1)  ·  David F Ransohoff, MD (1)  ·  Marissa Hall, PhD (1)  ·  Michael Wandell, PharmD. (1)  ·  Rohan Jeyarajah, MD (1)  ·  Saurav Haldar, MD (1)  ·  Timothy R Church, Ph.D. (1)

Results publications

PMID 23408352, PMID 24333512

NIH funding

R01AA030548 (1)